Position in PBYI
as of Mar 31, 2026
· filed Apr 20, 2026
Position Value
$4,947,828
+$818,523 QoQ
Shares Held
774,308
+11.6% QoQ
Ownership
1.52%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026RITHOLTZ WEALTH MANAGEMENT holds $29,107,183 across 20 Biotechnology names. PBYI ranks #1 (17.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PBYI |
Puma Biotechnology, Inc.
This page
|
774,308 | $4,947,828 | |
| 2 | AUPH |
Aurinia Pharmaceuticals Inc.
|
314,426 | $4,659,793 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
19,728 | $3,729,578 | |
| 4 | EXEL |
Exelixis, Inc.
|
77,962 | $3,343,790 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,850 | $2,165,719 | |
| 6 | RIGL |
Rigel Pharmaceuticals Inc
|
78,386 | $2,119,557 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
24,178 | $1,647,247 | |
| 8 | INVA |
Innoviva, Inc.
|
53,180 | $1,239,094 |
All Filings in PBYI
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,947,828 | 774,308 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $4,129,305 | 694,001 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $2,499,772 | 470,767 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $675,658 | 196,985 | Shares | Sole | 2025-07-28 | |
| 2024-12-31 | $61,390 | 20,128 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $55,080 | 21,600 | Shares | Sole | 2024-10-10 | |
| 2024-06-30 | $110,054 | 33,759 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $197,817 | 37,324 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $65,720 | 15,178 | Shares | Sole | 2024-01-18 | |
| No filing history on record for this holder in this stock. | ||||||